Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan Levin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Drugs in Dermatology : JDD|August 13, 2015
Emerging Oral Immunomodulators for the Treatment of Psoriasis: A Review of Phase III Clinical Trials for Apremilast and TofacitinibRachel McAndrew, Ethan Levin, John Koo
Dermatology and Therapy|November 17, 2017
The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic ReviewIsabelle M Sanchez, Eric Sorenson, Ethan Levin, et al.
Journal of Drugs in Dermatology : JDD|June 20, 2017
Case Report of Multiple Keratoacanthomas and Squamous Cell Carcinomas in a Patient Receiving PembrolizumabSoham Chaudhari, Argentina Leon, Ethan Levin, et al.
Dermatology Online Journal|July 10, 2015
Apremilast and adalimumab: a novel combination therapy for recalcitrant psoriasisMelissa J Danesh, Kourosh Beroukhim, Catherine Nguyen, et al.
The Journal of Dermatological Treatment|July 17, 2013
An update on drug-drug interactions with biologics for the treatment of moderate-to-severe psoriasisRishu Gupta, Ethan Levin, Jashin J Wu, et al.
The Journal of Dermatological Treatment|February 21, 2014
Anti-IL-17 phase II data for psoriasis: A reviewGabrielle Brown, Mona Malakouti, Eva Wang, et al.
The Journal of Dermatological Treatment|November 1, 2013
Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppressionEthan Levin, Rishu Gupta, Daniel Butler, et al.
JAMA Dermatology|March 26, 2015
Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host DiseaseEric Sorenson, Rachel McAndrew, Viraat Patel, et al.
Journal of Drugs in Dermatology : JDD|October 14, 2015
Anti-IL-23 Phase II Data for Psoriasis: A ReviewKourosh Beroukhim, Melissa J Danesh, Catherine Nguyen, et al.
Psoriasis (Auckland, N.Z.)|February 2, 2018
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasisSahil Sekhon, Caleb Jeon, Mio Nakamura, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Drugs in Dermatology : JDD|August 13, 2015
Emerging Oral Immunomodulators for the Treatment of Psoriasis: A Review of Phase III Clinical Trials for Apremilast and TofacitinibRachel McAndrew, Ethan Levin, John Koo
Dermatology and Therapy|November 17, 2017
The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic ReviewIsabelle M Sanchez, Eric Sorenson, Ethan Levin, et al.
Journal of Drugs in Dermatology : JDD|June 20, 2017
Case Report of Multiple Keratoacanthomas and Squamous Cell Carcinomas in a Patient Receiving PembrolizumabSoham Chaudhari, Argentina Leon, Ethan Levin, et al.
Dermatology Online Journal|July 10, 2015
Apremilast and adalimumab: a novel combination therapy for recalcitrant psoriasisMelissa J Danesh, Kourosh Beroukhim, Catherine Nguyen, et al.
The Journal of Dermatological Treatment|July 17, 2013
An update on drug-drug interactions with biologics for the treatment of moderate-to-severe psoriasisRishu Gupta, Ethan Levin, Jashin J Wu, et al.
The Journal of Dermatological Treatment|February 21, 2014
Anti-IL-17 phase II data for psoriasis: A reviewGabrielle Brown, Mona Malakouti, Eva Wang, et al.
The Journal of Dermatological Treatment|November 1, 2013
Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppressionEthan Levin, Rishu Gupta, Daniel Butler, et al.
JAMA Dermatology|March 26, 2015
Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host DiseaseEric Sorenson, Rachel McAndrew, Viraat Patel, et al.
Journal of Drugs in Dermatology : JDD|October 14, 2015
Anti-IL-23 Phase II Data for Psoriasis: A ReviewKourosh Beroukhim, Melissa J Danesh, Catherine Nguyen, et al.
Psoriasis (Auckland, N.Z.)|February 2, 2018
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasisSahil Sekhon, Caleb Jeon, Mio Nakamura, et al.
Pageof 2